ENGINEERED TOXIN BODY TARGETING TIGIT DEPLETES TREGS IN THE TUMOR MICROENVIRONMENT AND REDUCES TUMOR BURDEN IN MICE

被引：0

作者：

Saputra, Elizabeth ^{[1
]}

Chaudhary, Amit ^{[1
]}

Martinez, Desirae ^{[1
]}

Mitchell, Jennifer ^{[1
]}

Martin, Rebecca ^{[1
]}

Majercak, John ^{[1
]}

Dekker, Joseph ^{[1
]}

Moore, Chris ^{[1
]}

Khanna, Swati ^{[1
]}

机构：

[1] Mol Templates Inc, Austin, TX USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.1379

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1379

引用

页码：A1433 / A1433

页数：1

共 50 条

[1] ENGINEERED TOXIN BODY TARGETING CTLA-4 (MT8421) DEPLETES TREGS IN THE TUMOR MICROENVIRONMENT AND SYNERGIZES WITH αPD-1 TO ENHANCE T CELL IMMUNITY
Byrne, Lauren
Khanna, Swati
Martin, Rebecca
Howard, Caleigh
Rabia, Lilia
Sousares, Michaela
Zhao, Jay
Majercak, John
Poma, Eric
Moore, Chris
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A853 - A853
[2] Helicobacter hepaticus remodels the tumor immune microenvironment and reduces colorectal tumor burden
Overacre-Delgoffe, Abigail
Bumgarner, Hannah
Burr, Ansen
Hand, Timothy
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[3] Skeletal metastases: Decreasing tumor burden by targeting the bone microenvironment
Chirgwin, John M.
Guise, Theresa A.
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (06) : 1333 - 1342
[4] Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden
Martin, Erik W.
Buzza, Marguerite S.
Driesbaugh, Kathryn H.
Liu, Shihui
Fortenberry, Yolanda M.
Leppla, Stephen H.
Antalis, Toni M.
ONCOTARGET, 2015, 6 (32) : 33534 - 33553
[5] Intratumoral delivery of mPH-804 (TIGIT targeting INTASYL compound) inhibits tumor growth and confers an inflammatory tumor microenvironment
Lakshmikanthan, Sribalaji
Jedinak, Andrej
Maxwell, Melissa
Kadiyala, Mani
Yan, Dingxue
Cardia, James
Fricker, Simon
CANCER RESEARCH, 2020, 80 (16)
[6] Targeting oxygen metabolism reduces hypoxia in the tumor microenvironment of a syngeneic mouse model
Boreel, Daan F.
Span, Paul
Peters, Hans
van den Bijgaart, Renske J. E.
Heskamp, Sandra
Adema, Gosse J.
Bussink, Johan
MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
[7] Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.
Faustman, Denise L.
Torrey, Heather
Butterworth, John
Mera, Toshi
Okubo, Yoshiaki
Wang, Limei
Baum, Danielle
Warden, Sara
Plager, Sarah
Huang, Daniel
Vanamee, Eva
Foster, Rosemary
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
[8] Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
Wang, Jiao
Toregrosa-Allen, Sandra
Elzey, Bennett D.
Utturkar, Sagar
Lanman, Nadia Atallah
Bernal-Crespo, Victor
Behymer, Matthew M.
Knipp, Gregory T.
Yun, Yeonhee
Veronesi, Michael C.
Sinn, Anthony L.
Pollok, Karen E.
Brutkiewicz, Randy R.
Nevel, Kathryn S.
Matosevic, Sandro
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (45)
[9] Targeting the tumor microenvironment with the monoclonal antibody Tocilizumab, reduces IgM secretion in Waldenstrom macroglobulinemia
Han, Weiguo
Matissek, Stephan Josef
Jackson, David
Sklavanitis, Brandon
Elsawa, Sherine F.
JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
[10] Targeting neurons in the tumor microenvironment with bupivacaine nanoparticles reduces breast cancer progression and metastases
Kaduri, Maya
Sela, Mor
Kagan, Shaked
Poley, Maria
Abumanhal-Masarweh, Hanan
Mora-Raimundo, Patricia
Ouro, Alberto
Dahan, Nitsan
Hershkovitz, Dov
Shklover, Jeny
Shainsky-Roitman, Janna
Buganim, Yosef
Schroeder, Avi
SCIENCE ADVANCES, 2021, 7 (41)

← 1 2 3 4 5 →